Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infections, Meningococcal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00196950
What this trial is testing

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT00310674
What this trial is testing

Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age

Who this might be right for
Prevention of Meningococcal Infection
Novartis 150
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Large-scale testing (Phase 3)Study completedNCT02752906
What this trial is testing

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

Who this might be right for
MeningitisMeningococcal MeningitisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 810
Large-scale testing (Phase 3)Study completedNCT01340898
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Who this might be right for
Meningococcal Infection
GlaxoSmithKline 753
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Large-scale testing (Phase 3)Study completedNCT01148017
What this trial is testing

Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

Who this might be right for
Meningococcal Meningitis
Novartis Vaccines 433
Not applicableStudy completedNCT02287688
What this trial is testing

Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study

Who this might be right for
Meningococcal DiseaseInfections, Meningococcal
GlaxoSmithKline 144
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT01274897
What this trial is testing

A Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in Korea

Who this might be right for
Meningococcal DiseaseMeningococcal Meningitis
Novartis Vaccines 450
Large-scale testing (Phase 3)Active Not RecruitingNCT06226714
What this trial is testing

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 18-59 Year Olds

Who this might be right for
Meningococcal Meningitis
CanSino Biologics Inc. 840
Testing effectiveness (Phase 2)Study completedNCT00601731
What this trial is testing

Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

Who this might be right for
Meningococcal Disease
Novartis Vaccines 382
Large-scale testing (Phase 3)Study completedNCT01839175
What this trial is testing

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Who this might be right for
Neisseria MeningitidisBacterial InfectionsVirus Diseases
Sanofi Pasteur, a Sanofi Company 350
Not applicableStudy completedNCT05873751
What this trial is testing

Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.

Who this might be right for
GonorrheaChlamydiaMeningococcal Vaccines
Pfizer 1,307,378
Large-scale testing (Phase 3)Study completedNCT00197275
What this trial is testing

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

Who this might be right for
TetanusHepatitis BHaemophilus Influenzae Type b+2 more
GlaxoSmithKline 800
Early research (Phase 1)Study completedNCT00297687
What this trial is testing

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

Who this might be right for
Meningitis, Meningococcal
Wyeth is now a wholly owned subsidiary of Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT00258856
What this trial is testing

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 234
Large-scale testing (Phase 3)Study completedNCT03869866
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 290
Large-scale testing (Phase 3)Active Not RecruitingNCT07505888
What this trial is testing

Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years

Who this might be right for
Epidemic MeningitisMeningococcal Vaccines
Sinovac Biotech Co., Ltd 660
Testing effectiveness (Phase 2)Study completedNCT00427908
What this trial is testing

Study in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 613
Next Page